A new experimental medication for Alzheimer’s disease has demonstrated promising outcomes, aiding some patients in preserving their memory and cognitive functions. This drug, named buntanetap, has been evaluated in a clinical trial involving 351 participants with...
Mahajan Imaging & Labs has launched India's first AI-integrated blood biomarker test for early Alzheimer's detection. The USFDA- and CDSCO-approved pTAU217/βAmyloid1-42 plasma test identifies Alzheimer's pathology before severe cognitive decline sets in. Unveiled at a Gurugram...
